Contradictorily, c-Jun (4.21-fold) and c-Fos (18.56-fold), two important downstream targets of Ras/ERK pathway, were observed with significantly decreased expression at mRNA levels in tumor tissues (Figure 2B). The gene discussed is JUN; the disease is neoplasm.